Home

Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 25/12/03

Trade details

Type
Insider sale
Amount
$700,200
Shares · price
20,000 sh · $35.01 a share
Held after
92,083 sh
Trade date
25/12/01
Filed
25/12/03
Days to filing
2 days

Sold 17.8% of holdings

Share of holding sold
17.8%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/01~25/12/31

Christopher R. Cline's recent trades

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $3.3M

    Filed 09/15

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $101.7K

    Filed 05/06

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned saleTravere Therapeutics

    $101.7K

    Filed 05/05